Subscribe
Subscribe

Healthcare technology

Biomedical/pharma, Healthcare technology, Oncology, Personal/public health

ElmediX raises nearly 12 million euros to develop innovative heat technology to fight cancer

Mechelen, Belgium, January 25, 2022 - Belgian company ElmediX is developing intensive and controlled heat treatments for the treatment of cancer. A new capital injection of 4M euros brings the total to almost 12M euros (including VLAIO research grants worth 1.8M euros) and accelerates the trajectory of this innovative MedTech company.

Saving kidneys with a test that improves early detection of transplant rejection

Long COVID is a less talked-about aspect of the COVID-19 pandemic, yet its impact on society is already profound. Although this problem is still largely flying under the radar of the life sciences industry, a couple of first movers have already initiated clinical programs to address the condition. If more companies move into this space, long COVID may prove a catalyst for R&D in other related and underserved indications, like chronic fatigue syndrome.

A vision of the future: smart contact lenses to treat patients with iris disorders and light sensitivity

A woman opens her front door and looks to the sky to judge the weather. It’s sunny and inside her contact lenses, tiny microchips switch on layers of liquid crystals to protect her eyes from the bright light. Satisfied she won’t need a raincoat, the woman steps onto the street and goes about her day. It might sound like the start of a sci-fi novel, but this is the reality of Azalea Vision’s smart tech.

Betting on the best egg: Aurora test doubles pregnancy chances in assisted conception

Assisted conception techniques have matured in the last few decades, with Belgian scientists playing a big part in the progress. The Aurora test, developed by the Belgian start-up Fertiga, now further improves the odds for couples wanting to be parents: the test doubles the chances of becoming pregnant after just one fertility treatment.

Spectricity Raises €14 Million Series B Funding as it Accelerates Plans to Deliver Industry Leading Hyperspectral Sensing to Mobile and Consumer Devices

Funding Expands Growth for Tiny Chip-size Sensors for Unimaginable New Applications.

Azalea Vision closes € 8 million Series A to develop a smart contact lens for light sensitivity and ocular disorders

Azalea Vision develops autonomous smart solutions embedded inside a contact lens to improve the quality of life of people with light sensitivity or ocular disorders. The company has announced the closing of its Series A funding round, comprised of € 6.2 million in equity and € 1.8 million as a non-dilutive grant.

Ground-breaking Flemish health projects go virtual: Smart Hub Flemish Brabant launches Health Experience

Smart Hub Flemish Brabant has launched the innovative online platform ‘Health Experience’. The virtual tour gives exclusive insights into the ground-breaking projects of Materialise, imec, Health House, Rega Institute KU Leuven, Brussels Airport and B-PHOT Brussels Photonics.

Pulsify Medical closes second round Series A funding of EUR 6.35 million for wearable ultrasound heart monitor patch

Leuven, Belgium, 4 May 2021 - Pulsify Medical is a digital medical technology company developing wearable ultrasound patches which will monitor vital organs in real-time. The new and disruptive technology will address a serious unmet need for continuous cardiac monitoring in ICUs, hospitals, and homes across the world

DoseVue obtains CE Mark for its first in-vivo dosimetry product for radiation therapy

Diepenbeek, Belgium - January 28, 2021 - DoseVue NV, a privately held medical device company developing in-vivo dosimetry solutions for radiation therapy, today announces the CE marking of its first product: the DoseWire™ Series 200.

ElmediX wants to stop coronavirus by heating patients in a controlled manner

Mechelen, Belgium, 24 March 2020 - The coronavirus has brought the whole world to a standstill. The Belgian company ElmediX wants to contain the virus with intensive heat treatments for corona patients. Controlled heating to 41.5 °C for three hours can inactivate the virus and activate the patient's immune system. ElmediX has launched a call to researchers and doctors and makes the technology available in the fight against the coronavirus.

Combining disciplines for a simple sampling solution

Novosanis have been able to achieve great success with their clever yet simple urine sampling solution Colli-Pee®, largely thanks to their multidisciplinary approach to product development. We spoke with Novosanis CEO Vanessa Vankerckhoven about the company’s interesting origin story.

Pulsify Medical to develop a wearable heart monitor patch

Pulsify Medical, a joint imec and KU Leuven spin-off, has closed a seed funding round of €2.6 million. The investment, led by imec.xpand and KU Leuven, will be used to develop a wearable ultrasound patch to non-invasively monitor organs like the heart.

Pulsify Medical, a joint imec and KU Leuven spin-off, closes first-round funding, led by imec.xpand

Pulsify Medical will develop wearable ultrasound patches for non-invasive, real time monitoring of physiological parameters inside the body.